Speeding Up Antibody Discovery for Infectious Disease

Speeding Up Antibody Discovery for Infectious Disease

Tasked with an ambitious goal from DARPA to develop a rapid response to help medical workers fight viral diseases in the field, Vanderbilt University Medical Center has already reduced the time to develop antibodies significantly. High-throughput, synthetic genes from Twist Bioscience have allowed the lab to expedite this process.

Covered in this Case Study

  • A breakdown of DARPAs pandemic prevention platform from Vanderbilt University Medical Center.
  • The challenges of rapid antibody discovery.
  • How the scale of Twists Gene Synthesis enables a dramatically accelerated antibody discovery pipeline.

Share your details to Get the Case Study

Related Resources